Europe Cervical Cancer Mortality Rate is decreasing due to Government Efforts - Renub Research

Even though the fact that cervical cancer can be prohibited, approximately 60,000 women gets affected by the disease annually. Human papillomavirus (HPV) virus is the main cause of cervical cancer. Thanks to government screening program organized by most of European countries, deaths from cervical cancer has decreased over the past 30 years. Throughout this phase mortality rate has decreased; but still in present times one woman dies per 25,000 in European region. Our Report title “Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands)” provides details of the following points:

• Cervical Cancer Testing Population (Pap and HPV DNA)
• Cervical Cancer Testing Market ((Pap and HPV DNA)
• Cervical Cancer Mortality Population
• Countries Details (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands)

Germany is the Leader in European Cervical Cancer Testing Population
On the basis of general population, Germany is 2nd largest country in European region. It has good healthcare infrastructure. Germany offers widespread access to health care for the whole population, irrespective of income, insurance status, gender, age and social status. As for cancer care the quality standards are high. Generally, cervical cancer treatment and cervical cancer screening is strongly recommended by doctors and policy makers. Cervical cancer screening has been introduced more than 40 years ago; as a result cervical cancer incidence decreased by 70 percent. These enhancements are primarily due to usual cervical screening.

Pap Smear Test is Primary Test Method to Examine the Cervical Cancer in Europe
Pap smear test is most popular test method to know the cervical cancer among the European women. Pap test is also called as Papanicolaou test. It can be done in a few minutes by your doctor, nurse, community health in a clinic or consulting room. France, United Kingdom and Germany are most significant countries in the European region cervical cancer Pap smear test market. Europe accounts for a significant market share in global cervical cancer market.

Key Factors of which Cervical Cancer Test Become Popular in Europe
Healthcare infrastructure, per capita healthcare expenditure and government initiatives play a major role for cervical cancer test market across all European countries. Growing awareness about the importance of cervical cancer test among the women, healthcare companies and non-profit organizations (NGOs) initiatives are some other driving factors for this market.

For More Information: http://www.renub.com/europe-cervical-cancer-mortality-rate-is-decreasing-due-to-government-efforts-25-nd.php

Download full Report: http://www.renub.com/europe-cervical-cancer-test-market-patients-by-screening-type-pap-smear-hpv-dna-united-kingdom-france-germany-italy-spain-sweden-switzerland-norway-netherlands-989-p.php

Contact Us

Rajat Gupta
Business Development Manager
Email: info@renub.com
Phone: +1-678-302-0700 (USA), +91-120-421-9822 (India)
Web: http://www.renub.com

Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.

225 Kristie Ln, Roswell, GA 30076, United States

This release was published on openPR.